Amy Kirwan
Biographic Data
| ID | 5555102 |
|---|---|
| NAME | Amy Kirwan |
| GIVEN NAMES | Amy |
| FAMILY NAME | Kirwan |
| SIGNATURE | KIRWAN A |
| AFFILIATIONS | Burnet Institute |
| VERIFIED | No |
| TOTAL WORKS | 7 |
| TOTAL CITATIONS | 3 |
| AUTHOR COUNT | 7 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2018 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 1 |
Research as resistance: Operationalizing epistemic justice in domestic, family, and sexual violence research with criminalized women who use drugs
Background Epistemic justice requires that people hold meaningful authority over knowledge that concerns them. For criminalized women who use drugs, this authority is denied: overlapping credibility deficits across drug use, criminalization, and domestic, family, and sexual violence (DFSV) domains render their knowledge illegitimate, their accounts not credible, and their definitions of the problem absent from research. Existing lived experience …
The National Naloxone Reference Group: A collective voice on take‐home naloxone policy and practice in Australia
The National Naloxone Reference Group has played a key role in the development of take‐home naloxone programs, policy and practice in Australia. In this commentary we detail the origins of the group, some of its main achievements since its inception and its future directions in light of the major policy changes around naloxone that have recently occurred in Australia
The feasibility of a drug consumption room in the Australian Capital Territory
PMD has received investigator-driven research funding from Gilead Sciences for work on hepatitis C unrelated to this work. PMD has served as an unpaid member of an Advisory Board for an intranasal naloxone product
Emergency department presentations in the first weeks following release from prison among men with a history of injecting drug use in Victoria, Australia: A prospective cohort study
The Prison and Transition Health (Path) Cohort Study: Study Protocol and Baseline Characteristics of a Cohort of Men with a History of Injecting Drug Use Leaving Prison in Australia
People who inject drugs (PWID) are disproportionately represented among individuals who experience imprisonment and often have more complex physical and mental health needs than people in prison without injecting histories. The trajectories of PWID after prison release are poorly understood, hampering the development of effective strategies to address their distinct health needs. The Prison and Transition Health (PATH) Cohort Study is characteris…
Lifetime prevalence and correlates of self-harm and suicide attempts among male prisoners with histories of injecting drug use
BACKGROUND: Histories of self-harm and suicide attempts are common among people in prison in Australia, and substance dependence is an established risk factor for these lifetime experiences. We describe the prevalence of self-reported history of non-suicidal self-injury (NSSI) and suicide attempts in a cohort of men with recent histories of injecting drug use (IDU) imprisoned in Victoria, Australia. Baseline interviews from the Prison and Transit…
The associations of poor psychiatric well-being among incarcerated men with injecting drug use histories in Victoria, Australia
BACKGROUND: Dual substance dependence and psychiatric and psychological morbidities are overrepresented in prison populations and associated with reoffending. In the context of an increasing prison population in Australia, investigating the needs of vulnerable people in prison with a dual diagnosis can help inform in-prison screening and treatment and improve prison and community service integration and continuation of care. In this study we quan…
The Prison and Transition Health (Path) Cohort Study: Study Protocol and Baseline Characteristics of a Cohort of Men with a History of Injecting Drug Use Leaving Prison in Australia
People who inject drugs (PWID) are disproportionately represented among individuals who experience imprisonment and often have more complex physical and mental health needs than people in prison without injecting histories. The trajectories of PWID after prison release are poorly understood, hampering the development of effective strategies to address their distinct health needs. The Prison and Transition Health (PATH) Cohort Study is characteris…
Lifetime prevalence and correlates of self-harm and suicide attempts among male prisoners with histories of injecting drug use
BACKGROUND: Histories of self-harm and suicide attempts are common among people in prison in Australia, and substance dependence is an established risk factor for these lifetime experiences. We describe the prevalence of self-reported history of non-suicidal self-injury (NSSI) and suicide attempts in a cohort of men with recent histories of injecting drug use (IDU) imprisoned in Victoria, Australia. Baseline interviews from the Prison and Transit…
The associations of poor psychiatric well-being among incarcerated men with injecting drug use histories in Victoria, Australia
BACKGROUND: Dual substance dependence and psychiatric and psychological morbidities are overrepresented in prison populations and associated with reoffending. In the context of an increasing prison population in Australia, investigating the needs of vulnerable people in prison with a dual diagnosis can help inform in-prison screening and treatment and improve prison and community service integration and continuation of care. In this study we quan…
The Prison and Transition Health (Path) Cohort Study: Study Protocol and Baseline Characteristics of a Cohort of Men with a History of Injecting Drug Use Leaving Prison in Australia
People who inject drugs (PWID) are disproportionately represented among individuals who experience imprisonment and often have more complex physical and mental health needs than people in prison without injecting histories. The trajectories of PWID after prison release are poorly understood, hampering the development of effective strategies to address their distinct health needs. The Prison and Transition Health (PATH) Cohort Study is characteris…
The feasibility of a drug consumption room in the Australian Capital Territory
PMD has received investigator-driven research funding from Gilead Sciences for work on hepatitis C unrelated to this work. PMD has served as an unpaid member of an Advisory Board for an intranasal naloxone product
Emergency department presentations in the first weeks following release from prison among men with a history of injecting drug use in Victoria, Australia: A prospective cohort study
The National Naloxone Reference Group: A collective voice on take‐home naloxone policy and practice in Australia
The National Naloxone Reference Group has played a key role in the development of take‐home naloxone programs, policy and practice in Australia. In this commentary we detail the origins of the group, some of its main achievements since its inception and its future directions in light of the major policy changes around naloxone that have recently occurred in Australia
Research as resistance: Operationalizing epistemic justice in domestic, family, and sexual violence research with criminalized women who use drugs
Background Epistemic justice requires that people hold meaningful authority over knowledge that concerns them. For criminalized women who use drugs, this authority is denied: overlapping credibility deficits across drug use, criminalization, and domestic, family, and sexual violence (DFSV) domains render their knowledge illegitimate, their accounts not credible, and their definitions of the problem absent from research. Existing lived experience …
Medicine (6 works) · Psychology (6 works) · HIV, Drug Use, Sexual Risk (5 works) · Psychiatry (5 works) · Opioid Use Disorder Treatment (4 works) · Criminal Justice and Corrections Analysis (3 works) · Demography (3 works) · Drug (3 works) · Environmental health (3 works) · Internal Medicine (3 works)